- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 11, 2026 | 2.71M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 2.69M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 2.6M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $0 |
| Capex | Q1 2026 · Mar 31, 2025 | $22K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.58M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.06M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $11.01M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $13.71M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $16.47M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $17.31M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $9.09M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $9.13M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $10.34M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $10.04M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $23.26M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $24.16M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $26.92M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $27.47M |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.42 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.75 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.01M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $2.04M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.12M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$1.94M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.1M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$2.08M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $3.41M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $2.86M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $6.44M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $11.06M |